Sonoma Biotherapeutics
Thanmayi Ranganath is a Senior Research Manager for Lab Operations at Sonoma Biotherapeutics. She brings over 8 years of experience in life science research management. Prior to joining Sonoma Bio, she worked at the Stanford School of Medicine managing an immunology and infectious disease research lab. She has a wide range of experience in lab safety, vendor management, supervising clinical studies, managing budgets, and streamlining lab operations.
Thanmayi completed her M.A. in biomedical engineering from the University of California, Los Angeles, and an MBA from the Haas School of Business at the University of California, Berkeley.
This person is not in any offices
Sonoma Biotherapeutics
1 followers
Sonoma Biotherapeutics is developing engineered regulatory T cell (Treg) therapies to treat serious autoimmune and inflammatory diseases driven by an imbalanced immune system. Founded by pioneers in Treg biology and cell therapy, the company is employing proprietary platform technologies and approaches to develop a new generation of targeted Treg cell therapies designed to induce durable immune tolerance to treat and prevent autoimmune and inflammatory diseases. Sonoma Biotherapeutics is based in South San Francisco and Seattle.